121 related articles for article (PubMed ID: 1640864)
1. Estimation of plasma glucose fluctuation with a combination test of hemoglobin A1c and 1,5-anhydroglucitol.
Yamanouchi T; Moromizato H; Shinohara T; Minoda S; Miyashita H; Akaoka I
Metabolism; 1992 Aug; 41(8):862-7. PubMed ID: 1640864
[TBL] [Abstract][Full Text] [Related]
2. Plasma 1,5-anhydro-D-glucitol as new clinical marker of glycemic control in NIDDM patients.
Yamanouchi T; Minoda S; Yabuuchi M; Akanuma Y; Akanuma H; Miyashita H; Akaoka I
Diabetes; 1989 Jun; 38(6):723-9. PubMed ID: 2656341
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of 1,5-anhydroglucitol, hemoglobin A1c, and glucose levels in youth and young adults with type 1 diabetes and healthy controls.
Mehta SN; Schwartz N; Wood JR; Svoren BM; Laffel LM
Pediatr Diabetes; 2012 May; 13(3):278-84. PubMed ID: 22060802
[TBL] [Abstract][Full Text] [Related]
4. A new method of quantitating serum and urinary levels of 1,5-anhydroglucitol in insulin-dependent diabetes mellitus.
Namba N; Watanabe F; Tokuda M; Mino M; Furuya E
Diabetes Res Clin Pract; 1994 May; 24(1):55-61. PubMed ID: 7924887
[TBL] [Abstract][Full Text] [Related]
5. Effects of insulin on body composition in patients with insulin-dependent and non-insulin-dependent diabetes.
Sinha A; Formica C; Tsalamandris C; Panagiotopoulos S; Hendrich E; DeLuise M; Seeman E; Jerums G
Diabet Med; 1996 Jan; 13(1):40-6. PubMed ID: 8741811
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of 1,5-anhydroglucitol as a marker for glycemic variability in patients with type 2 diabetes mellitus.
Kim MJ; Jung HS; Hwang-Bo Y; Cho SW; Jang HC; Kim SY; Park KS
Acta Diabetol; 2013 Aug; 50(4):505-10. PubMed ID: 21688018
[TBL] [Abstract][Full Text] [Related]
7. Serum 1,5-Anhydroglucitol Concentrations Remain Valid as a Glycemic Control Marker In Diabetes with Earlier Chronic Kidney Disease Stages.
Bai Y; Yang R; Song Y; Wang Y
Exp Clin Endocrinol Diabetes; 2019 Apr; 127(4):220-225. PubMed ID: 29270924
[TBL] [Abstract][Full Text] [Related]
8. Mannose, mannitol, fructose and 1,5-anhydroglucitol concentrations measured by gas chromatography/mass spectrometry in blood plasma of diabetic patients.
Pitkänen E
Clin Chim Acta; 1996 Jul; 251(1):91-103. PubMed ID: 8814353
[TBL] [Abstract][Full Text] [Related]
9. Decreased serum 1,5-anhydroglucitol in nondiabetic subjects with a family history of NIDDM.
Tsukui S; Fukumura Y; Kobayashi I
Diabetes Care; 1996 Sep; 19(9):940-4. PubMed ID: 8875086
[TBL] [Abstract][Full Text] [Related]
10. Glycosylated serum proteins and glycosylated hemoglobin in the assessment of glycemic control in insulin-dependent and non-insulin-dependent diabetes mellitus.
Beisswenger PJ; Healy JC; Shultz EK
Metabolism; 1993 Aug; 42(8):989-92. PubMed ID: 8345823
[TBL] [Abstract][Full Text] [Related]
11. Reduction and recovery of plasma 1,5-anhydro-D-glucitol level in diabetes mellitus.
Yamanouchi T; Akanuma H; Asano T; Konishi C; Akaoka I; Akanuma Y
Diabetes; 1987 Jun; 36(6):709-15. PubMed ID: 3569670
[TBL] [Abstract][Full Text] [Related]
12. The glycemic index: similarity of values derived in insulin-dependent and non-insulin-dependent diabetic patients.
Wolever TM; Jenkins DJ; Josse RG; Wong GS; Lee R
J Am Coll Nutr; 1987 Aug; 6(4):295-305. PubMed ID: 3611527
[TBL] [Abstract][Full Text] [Related]
13. [Main causes of hyperuricemia in diabetes mellitus].
Madianov IV; Balabolkin MI; Markov DS; Markova TN
Ter Arkh; 2000; 72(2):55-8. PubMed ID: 10717929
[TBL] [Abstract][Full Text] [Related]
14. The use of 1.5-anhydroglucitol for monitoring glycemic control in islet transplant recipients.
Peixoto EM; Bozkurt NC; Messinger S; García MI; Lauriola V; Corrales A; Herrada E; Ricordi C; Alejandro R
Cell Transplant; 2014; 23(10):1213-9. PubMed ID: 23803279
[TBL] [Abstract][Full Text] [Related]
15. Serum 1,5-anhydro-D-glucitol and glycemic control in patients with non-insulin-dependent diabetes mellitus.
Umeda F; Yamauchi T; Ishii H; Nakashima N; Hisatomi A; Nawata H
Tohoku J Exp Med; 1991 Feb; 163(2):93-100. PubMed ID: 2048127
[TBL] [Abstract][Full Text] [Related]
16. Serum 1,5-anhydroglucitol level as a screening tool for diabetes mellitus in a community-based population at high risk of diabetes.
Wang Y; Yuan Y; Zhang Y; Lei C; Zhou Y; He J; Sun Z
Acta Diabetol; 2017 May; 54(5):425-431. PubMed ID: 27896445
[TBL] [Abstract][Full Text] [Related]
17. Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes.
Herman WH; Dungan KM; Wolffenbuttel BH; Buse JB; Fahrbach JL; Jiang H; Martin S
J Clin Endocrinol Metab; 2009 May; 94(5):1689-94. PubMed ID: 19276235
[TBL] [Abstract][Full Text] [Related]
18. Predicting long-term glycemic control of post-educational type II diabetic patients by evaluating serum 1,5-anhydroglucitol levels.
Sone H; Okuda Y; Yamaoka T; Kawakami Y; Odawara M; Matsushima T; Kawai K; Yamashita K
Diabetes Res Clin Pract; 1996 Oct; 34(2):83-8. PubMed ID: 9031810
[TBL] [Abstract][Full Text] [Related]
19. 1,5-Anhydroglucitol in diabetes mellitus.
Kim WJ; Park CY
Endocrine; 2013 Feb; 43(1):33-40. PubMed ID: 22847316
[TBL] [Abstract][Full Text] [Related]
20. Diurnal variation of blood ketone bodies in insulin-dependent diabetes mellitus and noninsulin-dependent diabetes mellitus patients: the relationship to serum C-peptide immunoreactivity and free insulin.
Ubukata E
Ann Nutr Metab; 1990; 34(6):333-42. PubMed ID: 2076025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
